REVIVA PHARMACEUTICALS HOLDINGS, INC. — DEF 14A Filings
8 DEF 14A filings on record
This page lists all DEF 14A filings submitted to the SEC by REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH), sorted by most recent first. Each row links to the full filing on EdgarLookup. REVIVA PHARMACEUTICALS HOLDINGS, INC. has filed 8 DEF 14A documents with the SEC since 2018. To view all SEC filings by REVIVA PHARMACEUTICALS HOLDINGS, INC., see the full filings list.
All
10-K
10-K/A
10-Q
25-NSE
3
4
424B3
424B4
424B5
425
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
EFFECT
NT 10-K
POS AM
POS EX
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEF 14A | FORM DEF 14A | 0001437749-25-033023 | Nov 4, 2025 | Dec 18, 2025 |
| DEF 14A | FORM DEF 14A | 0001437749-24-032297 | Oct 28, 2024 | Dec 10, 2024 |
| DEF 14A | FORM DEF 14A | 0001437749-23-027676 | Oct 4, 2023 | Nov 13, 2023 |
| DEF 14A | FORM DEF 14A | 0001437749-22-023855 | Oct 11, 2022 | Nov 10, 2022 |
| DEF 14A | FORM DEF 14A | 0001437749-21-024257 | Oct 26, 2021 | Dec 8, 2021 |
| DEF 14A | DEF 14A | 0001104659-20-103469 | Sep 9, 2020 | Sep 24, 2020 |
| DEF 14A | DEF 14A | 0001104659-20-057470 | May 6, 2020 | May 21, 2020 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001104659-20-011895 | Feb 6, 2020 | Feb 18, 2020 |